Insider sale
KYMERA THERAPEUTICS, INC.
$8.00M
88.78K shares
What this filing means
ATLAS VENTURE FUND X, L.P. plans to sell 88.78K shares of KYMERA THERAPEUTICS, INC. valued at approximately $8.00M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/15/2026ACC: 0001628280-26-025280
10% Owner
Since Aug 2020
88.78K
Shares to sell
$8.00M
Approx. market value
2.75K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Private Placement
Cash
3/11/2020
2.75KTotal acquired2.75K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/11/2020 | Private Placement Cash | 2.75K | — |
| Total | 2.75K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
4.16K
Market value
$374.2K
4/14/2026
—Completed
Units to sell
10.05K
Market value
$906.0K
3/2/2026
—Completed
Units to sell
71.81K
Market value
$6.47M
3/2/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
2.75K
Market value
$247.1K
4/15/2026
Total
Units
88.78K
Value
$8.00M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/14/2026 | 4.16K | $374.2K | — | Completed |
3/2/2026 | 10.05K | $906.0K | — | Completed |
3/2/2026 | 71.81K | $6.47M | — | Completed |
| Planned — Approximate Date | ||||
4/15/2026 | 2.75K | $247.1K | Nasdaq | Planned |
| Total | 88.78K | $8.00M | ||